| 699 | 0 | 230 |
| 下载次数 | 被引频次 | 阅读次数 |
目的 分析中国2015年新疆成年居民糖尿病和血脂异常的患病率、知晓率和控制率。方法 以2015年中国居民慢性病与营养监测调查数据为基础,选择新疆有完整人口学资料、糖尿病和血脂相关调查数据的18岁及以上成年人作为调查对象。结果 2015年新疆18岁及以上成年人糖尿病患病率为7.1%,男性(8.0%)高于女性(6.2%);城市(9.0%)高于农村(5.3%);≥60岁组糖尿病的患病率(13.7%)最高(P<0.05),18~44和45~59岁分别为2.4%、8.9%。血脂异常患病率为46.6%,其中低高密度脂蛋白胆固醇(HDL-C)血症患病率最高(34.0%)。男性血脂异常、高甘油三酯血症和低HDL-C血症的患病率均高于女性(P<0.05);城市(17.0%)高甘油三酯血症患病率高于农村(12.4%),农村(35.7%)低HDL-C血症患病率高于城市(31.9%)(P<0.05);高胆固醇血症和高LDL-C血症的患病率呈现年长者更高,低HDL-C血症患病率呈现年轻者更高(P<0.05)。本研究中糖尿病和血脂异常的知晓率分别为52.9%和18.1%,糖尿病和血脂异常患者的治疗率分别为46.2%和11.0%。成年女性的血脂异常知晓率和治疗率高于男性(P<0.05);城市居民血脂异常的知晓率、糖尿病和血脂异常患者的治疗率均高于农村(P<0.05);糖尿病、血脂异常的知晓率和治疗率均呈现随年龄增长的趋势(P<0.05)。结论 新疆糖尿病患病率略低于全国,但血脂异常问题突出,尤其是低HDL-C血症,且呈现年轻化趋势。
Abstract:OBJECTIVE To analyze the prevalence, awareness, and control rates of diabetes and dyslipidemia among adult residents in Xinjiang Uygur Autonomous Region in 2015.METHODS Based on data from the 2015 China Chronic Disease and Nutrition Surveillance, adults aged 18 years and older in Xinjiang with complete demographic information and data related to diabetes and blood lipids were selected as 4666 study subjects.RESULTS In 2015, the prevalence of diabetes among adults aged ≥18 years in Xinjiang Uygur Autonomous Region was 7.1%. The prevalence was significantly higher in men(8.0%) than in women(6.2%), and higher in urban(9.0%) than in rural(5.3%) areas. By age group, the prevalence was highest in adults aged ≥60 years(13.7%), followed by those aged 45-59 years(8.9%) and 18-44 years(2.4%)(all P<0.05).The prevalence of dyslipidemia was 46.6%, with low high-density lipoprotein cholesterol(HDL-C) being the most prevalent subtype(34.0%). The prevalence rates of dyslipidemia, hypertriglyceridemia, and low HDL-C were significantly higher in males than in females(P<0.05). The prevalence of hypertriglyceridemia was higher in urban(17.0%) than in rural areas(12.4%), while the prevalence of low HDL-C was higher in rural(35.7%) than in urban areas(31.9%)(P<0.05). The prevalence of hypercholesterolemia and high LDL-C was higher in older adults, whereas that of low HDL-C was higher in younger adults(P<0.05). In this study, the awareness rates for diabetes and dyslipidemia were 52.9% and 18.1%, respectively. The treatment rates among patients with diabetes and dyslipidemia were 46.2% and 11.0%, respectively. Awareness and treatment rates for dyslipidemia were higher in adult females than in males(P<0.05). Urban residents had higher awareness rates for dyslipidemia and higher treatment rates for both diabetes and dyslipidemia than rural residents(P<0.05). Awareness and treatment rates for both diabetes and dyslipidemia showed increasing trends with age(P<0.05).CONCLUSION The prevalence of diabetes in Xinjiang is slightly lower than the national average, but dyslipidemia is prominent, particularly low HDL-C,with a noticeable trend of younger onset.
[1] 国际糖尿病联盟.全球糖尿病地图(第11版)[R].曼谷:2025世界糖尿病大会,2025.
[2] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J].中华糖尿病杂志,2021,13(4):315-409.
[3] 刘明波,何新叶,杨晓红,等.《中国心血管健康与疾病报告2023》要点解读[J].中国心血管杂志,2024,29(4):305-324.
[4] SONG P K,MAN Q Q,LI H,et al.Trends in lipids level and dyslipidemia among Chinese adults,2002-2015[J].Biomed Environ Sci,2019,32(8):559-570.
[5] 戴璟,闵杰青,杨云娟.中国九省市成年人血脂异常流行特点研究[J].中华心血管病杂志,2018,46(2):114-118.
[6] YU D M,ZHAO L Y,ZHANG J,et al.China nutrition and health surveys (1982-2017)[J].China CDC Wkly,2021,3(9):193-195.
[7] 赵丽云,郭齐雅,李淑娟,等.加强营养调查与监测,改善中国居民营养与健康状况[J].卫生研究,2019,48(4):517-522.
[8] 中国血脂管理指南修订联合专家委员会.中国血脂管理指南(2023年)[J].中华心血管病杂志,2023,51(3):221-255.
[9] 李亚鹏,马儒林,张眉,等.2010年新疆维吾尔族、哈萨克族及汉族成年人血脂异常的流行特点[J].中华预防医学杂志,2013,47(10):949-953.
[10] WANG L M,GAO P,ZHANG M,et al.Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013[J].JAMA,2017,317(24):2515-2523.
[11] 金梦龙,秦晓英,马力亚·阿米提,等.新疆哈萨克族血脂异常、高血压和糖尿病共病现状及影响因素研究[J].中国全科医学,2024,27(12):1438-1444.
[12] 李应琴,张荣民,赵炜,等.新疆阿克苏市良种场维吾尔族农村居民2型糖尿病患病率和危险因素的调查[J].新疆医科大学学报,2013,36(9):1375-1378.
[13] 张周斌,薛振香,汪慧,等.新疆喀什地区维吾尔族人群糖尿病患病情况及相关危险因素研究[J].中华流行病学杂志,2017,38(6):696-701.
[14] ZHAO F F,MAMATYUSUPU D,WANG Y X,et al.The Uyghur population and genetic susceptibility to type 2 diabetes:potential role for variants in CAPN10,APM1 and FUT6 genes[J].J Cell Mol Med,2016,20(11):2138-2147.
[15] SIKHAYEVA N,TALZHANOV Y,ISKAKOVA A,et al.Type 2 diabetes mellitus:distribution of genetic markers in Kazakh population[J].Clin Interv Aging,2018,13:377-388.
[16] JAIN I H,ZAZZERON L,GOLI R,et al.Hypoxia as a therapy for mitochondrial disease[J].Science,2016,352(6281):54-61.
[17] 张竞,罗蕴之,李素丽,等.新疆乌鲁木齐维吾尔族≥18岁居民糖尿病患病率及其影响因素调查[J].中国热带医学,2020,20(9):826-830.
[18] 艾飞玲,曹雪,李小春,等.基于前瞻性队列研究的亚洲成人吸烟与2型糖尿病发生风险关系的Meta分析[J].中华健康管理学杂志,2020,14(3):251-259.
[19] 金茜,冯烨.雌激素在糖代谢中的作用[J].浙江医学,2024,46(22):2440-2444.
[20] GUO J,HUANG X Q,DOU L,et al.Aging and aging-related diseases:from molecular mechanisms to interventions and treatments[J].Signal Transduct Target Ther,2022,7(1):391.
[21] 贾铭,彭菊意,刘星宇,等.心血管代谢性共病危险因素的Meta分析[J].预防医学,2023,35(9):790-795.
[22] 赵丽云,丁刚强,赵文华.2015—2017年中国居民营养与健康状况监测报告[M].北京:人民卫生出版社,2022.
[23] 张荣,张云君,甫尔哈提·吾守尔,等.2013—2014年新疆维吾尔自治区成年居民血脂异常流行状况及其相关因素[J].中华预防医学杂志,2018,52(11):1152-1157.
[24] ZHANG M,DENG Q,WANG L H,et al.Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults:a nationally representative survey of 163,641 adults[J].Int J Cardiol,2018,260:196-203.
[25] OPOKU S,GAN Y,FU W N,et al.Prevalence and risk factors for dyslipidemia among adults in rural and urban China:findings from the China National Stroke Screening and prevention project (CNSSPP)[J].BMC Public Health,2019,19(1):1500.
[26] LU Y,ZHANG H B,LU J P,et al.Prevalence of dyslipidemia and availability of lipid-lowering medications among primary health care settings in China[J].JAMA Netw Open,2021,4(9):e2127573.
[27] 金梦龙,马吾苏木·马木特,合巴丽·沙帕尔买买提,等.新疆帕米尔高原塔吉克族血脂异常患病率及相关因素分析[J].中华心血管病杂志,2023,51(12):1240-1246.
[28] 李亚鹏,丁玉松,马儒林,等.新疆维吾尔族成人血脂异常及其影响因素分析[J].中华内分泌代谢杂志,2013,29(8):690-692.
[29] EBTEHAJ S,GRUPPEN E G,BAKKER S J L,et al.HDL (High-Density lipoprotein) cholesterol efflux capacity is associated with incident cardiovascular disease in the general population[J].Arterioscler Thromb Vasc Biol,2019,39(9):1874-1883.
[30] 哈晓丹,王翠喆,李伟,等.新疆地区汉族、维吾尔族和哈萨克族脂代谢异常检出率分析[J].石河子大学学报(自然科学版),2016,34(1):63-68.
[31] 胡云华,刘佳铭,张眉,等.CETP基因多态性及其单体型与新疆维吾尔族、哈萨克族人群血脂异常的相关性[J].中华心血管病杂志,2016,44(8):671-677.
[32] 罗思富,金梦龙,苏比努尔·居热提,等.不同民族动脉粥样硬化性心血管疾病患者中等剂量他汀类药物治疗的疗效差异研究[J].中国全科医学,2024,27(36):4522-4526.
基本信息:
DOI:10.19813/j.cnki.weishengyanjiu.2026.02.003
中图分类号:R587.1;R589.2
引用信息:
[1]许晓丽,李淑娟,郭齐雅,等.2015年新疆成年居民糖尿病和血脂异常状况[J].卫生研究,2026,55(02):188-194.DOI:10.19813/j.cnki.weishengyanjiu.2026.02.003.
基金信息:
国家财政项目:公共卫生应急-营养健康与合理膳食行动(No.102393220020070000012); 国家重大公共卫生服务项目[中国成人慢性病与营养监测(2015年)]
2026-03-19
2026-03-19